A decline in the frequency of neonatal exchange transfusions and its effect on exchange-related morbidity and mortality

Pediatrics

Volumn 120, Issue 1, 2007, Pages 27-32

  Steiner, Laurie A ^a   Bizzarro, Matthew J ^a   Ehrenkranz, Richard A ^a   Gallagher, Patrick G ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Complication; Exchange transfusion; Hyperbilirubinemia; Neonate

Indexed keywords

CLINICAL PRACTICE; CONTROLLED STUDY; EXCHANGE BLOOD TRANSFUSION; HUMAN; HYPERBILIRUBINEMIA; HYPOCALCEMIA; MAJOR CLINICAL STUDY; MORBIDITY; MORTALITY; PRIORITY JOURNAL; REVIEW; THROMBOCYTOPENIA;

EXCHANGE TRANSFUSION, WHOLE BLOOD; FEMALE; HUMANS; HYPERBILIRUBINEMIA, NEONATAL; HYPOCALCEMIA; INFANT, NEWBORN; MALE; THROMBOCYTOPENIA;

EID: 34447137345     PISSN: 00314005     EISSN: 02105721     Source Type: Journal    
DOI: 10.1542/peds.2006-2910     Document Type: Review

References (28)

1. Diamond LK, Allen FH Jr, Thomas WO Jr. Erythroblastosis fetalis: VII. Treatment with exchange transfusion. N Engl J Med. 1951;244:39-49
2. Lucey JF. Changing concepts regarding exchange transfusion and neonatal jaundice. Clin Obstet Gynecol. 1971;14:586-593
3. Lucey JF. The future demise of exchange transfusions for neonatal hyperbilirubinemia. Dev Med Child Neurol. 1968;10:521-522
4. Maisels MJ. Phototherapy: traditional and nontraditional. J Perinatol. 2001;21:S93-S97
5. Bowman JM. Nathan and Oski's Hematology of Infancy and Childhood. 5th ed. Philadelphia, PA: WB Saunders; 1993
6. Harman CR, Manning FA, Bowman JM, Lange IR. Severe Rh disease: poor outcome is not inevitable. Am J Obstet Gynecol. 1983;145:823-829
7. Dukler D, Oepkes D, Seaward G, Windrim R, Ryan G. Noninvasive tests to predict fetal anemia: a study comparing Doppler and ultrasound parameters. Am J Obstet Gynecol. 2003;188:1310-1314
8. Mari G, Deter RL, Carpenter RL, et al. Noninvasive diagnosis by Doppler ultrasonography of fetal anemia due to maternal red-cell alloimmunization. Collaborative group for Doppler assessment of the blood velocity in anemic fetuses. N Engl J Med. 2000;342:9-14
9. Valaes, T, Koliopoulous C, Koliopoulous A. The impact of phototherapy in the management of neonatal hyperbilirubinemia: comparison of historical cohorts. Acta Paediatr. 1996;85:273-276
10. Guaran RL, Drew JH, Watkins AM. Jaundice: clinical practice in 88,000 liveborn infants. Aust N Z J Obstet Gynaecol. 1992;32:186-192
11. Yi-Yung Has D, Allan FH, Gellis SS, Diamond LK. Erythroblastosis fetalis: VIII. Studies of serum bilirubin in relation to kernicterus. N Engl J Med. 1952;247:668-671
12. Watchko JF, Oski FA. Bilirubin 20 mg/dL = vigintiphobia. Pediatrics. 1983;71:660-663
13. Newman TB, Maisels MJ. Does hyperbilirubinemia damage the brain of healthy full term infants? Clin Perinatol. 1990;17:331-358
14. Newman TB, Maisels MJ. Evaluation and treatment of jaundice in the term newborn: a kinder, gentler approach. Pediatrics. 1992;89:809-818
15. American Academy of Pediatrics, Provisional Committee of Quality Improvement and Subcommittee on Hyperbilirubinemia. Practice Parameter: management of hyperbilirubinemia in the healthy term newborn [published correction appears in Pediatrics. 1995;95:458-461]. Pediatrics. 1994;94:558-562
16. Watchko, JF. Vigintiphobia revisited. Pediatrics. 2005;115:1747-1753
17. Peterec SM. Management of neonatal Rh disease. Clin Perinatol. 1995;22:561-592
18. Edwards MC, Fletcher MA. Exchange transfusions. In: Fletcher MA, MacDonald MG, Avery GB, eds. Procedures in Neonatology. Philadelphia, PA: JB Lippincott Company; 1983:313-326
19. Papile LA, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1500 g. J Pediatr. 1978;92:529-534
20. Walsh MC, Kliegman RM, Fanaroff AA. Necrotizing enterocolitis: a practitioner's perspective. Pediatr Rev. 1988;9:219-226
21. Jackson, JC. Adverse events associated with exchange transfusion in healthy and ill newborns. Pediatrics. 1997:99(5). Available at: www.pediatrics.org/cgi/content/full/99/5/e7
22. Patra K, Storfer-Esser A, Siner B, Moore J. Adverse events associated with neonatal exchange transfusions in the 1990's. J Pediatr. 2004;144:626-631
23. Gottstein R, Cooke RW. Systematic review of immunoglobulin in haemolytic disease of the newborn. Arch Dis Child Fetal Neonatal Ed. 2003;88:6-10
24. Ip S, Chung M, Kulig J, et al. An evidence-based review of important issues concerning neonatal hyperbilirubinemia. Pediatrics. 2004;114(1). Available at www.pediatrics.org/cgi/content/full/114/1/e130
25. Boggs TR Jr, Westphal MC Jr. Mortality of exchange transfusion. Pediatrics. 1960;26:744-745
26. Weldon V, Odell G. Mortality risk of exchange transfusion. Pediatrics. 1968;41:797-801
27. Keenan WJ, Novak KK, Sutherland JM, Bryla DA, Fetterly KL. Morbidity and mortality associated with exchange transfusion. Pediatrics. 1985;75(suppl):422-426
28. American Academy of Pediatrics, Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 weeks or more of gestation [published correction appears in Pediatrics. 2004;114:1138]. Pediatrics. 2004;114:297-316